National Track and Trace Proposal Would Curtail State ePedigree Plans
A new bipartisan track and trace proposal floated by House and Senate lawmakers last week would implement a uniform national policy on drug product tracing, heading off state-by-state initiatives.
The new legislation, still in draft form, would be implemented in two phases, with unit-level serialization taking place first and unit-level tracking and authentication following at a later unspecified time, a provision that will please drugmakers concerned about having to comply with a patchwork of state laws.
California’s ePedigree law, set to take effect in 2015, is widely considered to be the strongest proposal to date, implementing simultaneous unit-level serialization, tracking and authentication.
If a new track-and-trace proposal or new guidance from the FDA will affect your company, FDAnews’ Washington Drug Letter will provide you with weekly reports covering industry and regulatory pharmaceutical news.
For an executive on the go, this weekly publication is a must-have to be in command of valuable knowledge that will keep you one step ahead of the rest. Subscribe today!
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!